2 | $VVNT 20% v1,75M c8.44 f212,768M H9.0 ML5.95 | znewcar1 | 11/09/2022 7:20:24 PM |
1 | VVNT 19% v1,4M c6.47 f212,6M H6.59 | znewcar1 | 05/04/2022 4:35:41 PM |
Recent Articles
- Essential Guidance for DoubleVerify Investors Facing Losses
- Organon & Co. Legal Notice: Action for Investors Ahead
- Hudbay Minerals' Response to Wildfire Impact on Operations
- Rubicon Organics Announces Details for Upcoming Shareholder Meeting
- Join Rubicon Organics for Insightful Annual Meeting in 2025
- Goodfellow Inc. Expands Board with Suzanne Blanchet Appointment
- Goodfellow Inc. Strengthens Leadership with New Appointment
- Churchill Resources Closes $700,000 Private Placement Successfully
- TC Energy's Upcoming Financial Results Conference Call
- TC Energy Prepares for Financial Q2 2025 Announcement
- Goodfellow Inc. Financial Performance Update: Key Insights
- Tim Lamb Group Completes Successful Sale of Ohio Dealership
- Bitcoin's Rise Sparks Unprecedented Mining Demand with PaladinMining
- Understanding Baker Hughes' P/E Ratio: A Comprehensive Analysis
- Apple's Foldable iPhone Expected to Launch in 2026
- How $1,000 in XRP Token Could Have Grown Since Snoop Dogg's Show
- Transform Your Investment with Constellation Brands Today
- Goodfellow Inc. Shows Resilience Despite Market Challenges
- Avient Corporation Declares New Quarterly Dividend Payment
- Mountain Laurel Dermatology Addresses Recent Data Security Breach
- Tronox Prepares for Earnings Release and Webcast Call Details
- Ramaco Resources Shares Insights on Preliminary Economic Assessment
- Vermilion Energy Completes Significant Asset Sale for Growth
- Rollins, Inc. Sets Date for Upcoming Financial Results Report
- Sandstorm Gold Royalties Achieves Record Quarter with Strong Sales
- How a $100 Investment in Axis Capital Could Grow Over Time
- Flutter Entertainment Boosts Stake in FanDuel to 100%
- Vital Update for Rocket Pharmaceuticals Investors Regarding Class Action
- Integer Holdings Corporation Welcomes Michael Coyle to Board
- Investors Target Class Action for Iovance Biotherapeutics Losses
- Reddit, Inc. Faces Legal Challenges: Key Updates for Shareholders
- Legal Action Impacting Hims & Hers Health, Inc. (HIMS) Investors
- Churchill Resources Secures $700,000 in New Funding Round
- Krispy Kreme Investors Take Action After Significant Losses
- Integer Appoints New Director from Medical Device Sector
- Vestis Corporation Investors Urged to Secure Rights ASAP
- Stallion Uranium Enhances Technology Data Acquisition Agreement
- Your Rights as Shareholders in Organon & Co. Class Action
- 3D Systems Corporation Lawsuit Notification: What Investors Should Know
- Understand the Ongoing Securities Class Action Against SRPT
- Potential Class Action for DoubleVerify Holdings Shareholders
- Class Action Alert: PepGen Inc. Faces Securities Law Issues
- Investors Encouraged to Join Class Action Against Petco for Losses
- Levi Strauss Reports Strong Q2 Performance with Positive Outlook
- Boyd Gaming Announces Strategic Sale of FanDuel Stake for $1.755B
- Sharp's Award Wins at InfoComm 2025 Highlights Innovation
- Little Pepe's Presale Hits $4.8M, Exciting Stage 5 Launch
- Proficient Auto Logistics Earns Top Honors from Toyota
- Flutter's Strategic Move: Full Control of FanDuel for Growth
- Crinetics Pharmaceuticals Expands Employee Incentives with New Grants